These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16916451)

  • 1. Nociceptors in cardiovascular functions: complex interplay as a result of cyclooxygenase inhibition.
    Premkumar LS; Raisinghani M
    Mol Pain; 2006 Aug; 2():26. PubMed ID: 16916451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloprost-induced nociception: determination of the site of anti-nociceptive action of cyclooxygenase inhibitors and the involvement of cyclooxygenase products in central mechanisms of nociception.
    Ayoub SS; Botting RM
    Methods Mol Biol; 2010; 644():207-15. PubMed ID: 20645177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J; Kowalski ML
    Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites.
    Burian M; Geisslinger G
    Pharmacol Ther; 2005 Aug; 107(2):139-54. PubMed ID: 15993252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol (Acetaminophen): mechanisms of action.
    Anderson BJ
    Paediatr Anaesth; 2008 Oct; 18(10):915-21. PubMed ID: 18811827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta.
    Qi Z; Cai H; Morrow JD; Breyer MD
    Hypertension; 2006 Aug; 48(2):323-8. PubMed ID: 16801485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages.
    Woo HG; Lee CH; Noh MS; Lee JJ; Jung YS; Baik EJ; Moon CH; Lee SH
    Planta Med; 2001 Aug; 67(6):505-9. PubMed ID: 11509968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of different arachidonic acid orientations bound to prostaglandin endoperoxide synthases.
    Sachett LG; Verli H
    Eur J Med Chem; 2011 Oct; 46(10):5212-7. PubMed ID: 21864948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
    Huang JC; Wun WS; Goldsby JS; Matijevic-Aleksic N; Wu KK
    Hum Reprod; 2004 Dec; 19(12):2900-6. PubMed ID: 15489241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cyclo-oxygenase-2.
    Stack E; DuBois RN
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
    Beltrán B; Moreno L; Esplugues JV
    Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
    [No Abstract]   [Full Text] [Related]  

  • 16. Getting to the heart of COX-2 inhibition.
    Breyer MD
    Cell Metab; 2005 Sep; 2(3):149-50. PubMed ID: 16154096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.
    Reuter BK; Asfaha S; Buret A; Sharkey KA; Wallace JL
    J Clin Invest; 1996 Nov; 98(9):2076-85. PubMed ID: 8903327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.
    Su X; Riedel ES; Leon LA; Laping NJ
    Neurourol Urodyn; 2008; 27(3):249-53. PubMed ID: 17598175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors.
    Walch L; Morris PL
    Endocrinology; 2002 Sep; 143(9):3276-83. PubMed ID: 12193539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
    Vanegas H
    Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.